Taris Biomedical LLC
Overview
Taris Biomedical LLC is a private biotechnology company focused on developing innovative therapies in urology. It specializes in delivering treatment directly to the bladder with sustained release technology. In 2019, it was acquired by Johnson & Johnson.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Taris Biomedical LLC in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.